Sezary Syndrome - Global Clinical Trials Review, H1, 2021
- $ 2500
- May 2024
- 145 pages
Acute Lymphoblastic Lymphoma, Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Advanced Malignancy, Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, B-Cell Non-Hodgkin Lymphoma, Brain Cancer, Burkitt Lymphoma, Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma, Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma), Follicular Lymphoma, Hairy Cell Leukemia, Hepatocellular Carcinoma, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Intestinal Cancer, Liver Cancer, Lymphoblastic Lymphoma, Lymphoma, Mantle Cell Lymphoma, Mycosis Fungoides, Natural Killer Cell Lymphomas, Non-Hodgkin Lymphoma, Sezary Syndrome, Solid Tumor, T-Cell Leukemia, T-Cell Lymphomas, Testicular Cancer, Unspecified B-Cell Lymphomas, Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)